Department of Physical Medicine and Rehabilitation, Emory University School of Medicine, Atlanta, GA; Department of Orthopaedics, Emory University School of Medicine, Atlanta, GA.
Department of Physical Medicine and Rehabilitation, Emory University School of Medicine, Atlanta, GA; Department of Orthopaedics, Emory University School of Medicine, Atlanta, GA.
Tech Vasc Interv Radiol. 2020 Dec;23(4):100704. doi: 10.1016/j.tvir.2020.100704. Epub 2020 Oct 6.
Biologics are a growing field that has shown immense promise for the treatment of musculoskeletal conditions both in orthopedic sports medicine and interventional pain management. These procedures utilize injection of supraphysiologic levels of platelets and growth factors to invoke the body's own inflammatory cascade to augment the healing of many bony and soft tissue conditions. While many patients improve with conservative care, there is a need to address the gap between those that improve with rehabilitation alone and those who ultimately require operative management. Orthobiologic procedures have the potential to fill this void. The purpose of this review is to summarize the basic science, evidence for use, and post-injection rehabilitation concepts of platelet-rich plasma (PRP) and mesenchymal stromal cells (MSCs) as they pertain to joints, tendons, ligaments, and the spine.
生物制剂是一个不断发展的领域,在运动医学和介入疼痛管理的肌肉骨骼疾病治疗方面显示出了巨大的潜力。这些程序利用注射超生理水平的血小板和生长因子来引发身体自身的炎症级联反应,以增强许多骨和软组织疾病的愈合。虽然许多患者通过保守治疗得到改善,但需要解决那些仅通过康复改善的患者和最终需要手术治疗的患者之间的差距。骨科生物制剂有潜力填补这一空白。本综述的目的是总结富血小板血浆(PRP)和间充质基质细胞(MSCs)的基础科学、使用证据和注射后康复概念,因为它们与关节、肌腱、韧带和脊柱有关。